Robert Kim

Robert Kim formerly worked at Genentech, Inc., as Senior Medical Director from 2003 to 2006, Novartis AG, as Vice President from 2012 to 2014, Carl Zeiss Meditec, Inc., as Senior Scientist from 1999 to 2001, The University of California, San Francisco, as Associate Clinical Professor-Ophthalmology from 1994 to 2025, 4D Molecular Therapeutics, Inc., as Chief Medical Officer from 2023 to 2025, Apellis Pharmaceuticals, Inc., as Chief Medical Officer from 2016 to 2017, Alcon Laboratories, Inc., as VP & Head-Pharmaceutical Product Development from 2012 to 2014, Viewpoint Therapeutics, Inc., as Chief Medical Officer from 2018 to 2020, and Vision Medicines, Inc., as Chief Medical Officer from 2014 to 2016.
Dr. Kim received his undergraduate degree in 1982 and doctorate degree in 1985 from Brown University and Masters Business Admin degree in 2000 from Haas School of Business.